Associated Banc-Corp’s Guardant Health GH Stock Holding History

Associated Banc-Corp’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-19	Closed	-$2K	–	528
2020 Q4	$2K	Buy	19 +9	+90%	+$1.04K	﹤0.01%	777
2020 Q3	$1K	Buy	+10	New	+$915	﹤0.01%	873

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Associated Banc-Corp's GH Position: Q1 2021 in Review

Associated Banc-Corp sold out of Guardant Health (GH) in Q1 2021, closing a stake of 19 shares — an estimated $2K sold.

Associated Banc-Corp first reported a position in GH in Q3 2020 and held it in 2 quarters. The position peaked at $2K in Q4 2020. 419 funds tracked by Wall St. Rank hold GH as of Q1 2021.

Associated Banc-Corp reported no remaining Guardant Health position as of Q1 2021 after selling out during the quarter.
Associated Banc-Corp sold 19 Guardant Health shares in Q1 2021, an estimated $2K.
Associated Banc-Corp first reported a position in Guardant Health in Q3 2020 and held it in 2 quarters.
Associated Banc-Corp's Guardant Health position peaked at $2K in Q4 2020.
419 funds tracked by Wall St. Rank held Guardant Health as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.